THERAPEUTIC AGENT FOR STRESS URINARY INCONTINENCE AND FECAL INCONTINENCE

摘要

Provided are: a therapeutic agent for fecal incontinence; and a therapeutic agent for stress urinary incontinence, which is reduced in adverse side effects including an effect to induce body weight loss. Provided are: a therapeutic agent for diseases including fecal incontinence; and a therapeutic agent for diseases including fecal incontinence, which is reduced in adverse side effects including an effect to induce body weight loss. A medicine for treating stress urinary incontinence, which contains a 5-HT_2C receptor agonist and can be administered in a lower dose amount than the lowest dose amount thereof for use as an anti-obesity drug. A medicine for treating or preventing fecal incontinence or the like, which contains a 5-HT_2C receptor agonist. A medicine for treating fecal incontinence, which contains a 5-HT_2C receptor agonist and can be administered in a lower dose amount than the lowest dose amount thereof for use as an anti-obesity drug.